102 related articles for article (PubMed ID: 23073595)
1. [Expression of parafibromin in human osteosarcoma of the jaws].
Sima ZH; Chen Y; Li TJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):792-6. PubMed ID: 23073595
[TBL] [Abstract][Full Text] [Related]
2. HRPT2 gene alterations in ossifying fibroma of the jaws.
Pimenta FJ; Gontijo Silveira LF; Tavares GC; Silva AC; Perdigão PF; Castro WH; Gomez MV; Teh BT; De Marco L; Gomez RS
Oral Oncol; 2006 Aug; 42(7):735-9. PubMed ID: 16458039
[TBL] [Abstract][Full Text] [Related]
3. Evidence of molecular alterations in the tumour suppressor gene WWOX in benign and malignant bone related lesions of the jaws.
Diniz MG; Borges ER; Pimenta FJ; De Mesquita Netto AC; De Marco L; Gomez RS; Gomes CC
Oncol Rep; 2011 Feb; 25(2):499-502. PubMed ID: 21165567
[TBL] [Abstract][Full Text] [Related]
4. Assessing the contribution of HRPT2 to the pathogenesis of jaw fibrous dysplasia, ossifying fibroma, and osteosarcoma.
de Mesquita Netto AC; Gomez RS; Diniz MG; Fonseca-Silva T; Campos K; De Marco L; Carlos R; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):359-67. PubMed ID: 23453027
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical assessment of parafibromin in mouse and human tissues.
Porzionato A; Macchi V; Barzon L; Masi G; Iacobone M; Parenti A; Palù G; De Caro R
J Anat; 2006 Dec; 209(6):817-27. PubMed ID: 17118068
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function.
Lin L; Czapiga M; Nini L; Zhang JH; Simonds WF
Mol Cancer Res; 2007 Feb; 5(2):183-93. PubMed ID: 17314275
[TBL] [Abstract][Full Text] [Related]
7. [Juvenile ossifying fibroma: a misgiving tumor of the jaws].
Odin G; Benchetrit M; Raybaud H; Balaguer T; Soler C; Michiels JF
Ann Pathol; 2012 Feb; 32(1):65-7. PubMed ID: 22325316
[TBL] [Abstract][Full Text] [Related]
8. Cemento-ossifying fibroma and benign cementoblastoma.
El-Mofty SK
Semin Diagn Pathol; 1999 Nov; 16(4):302-7. PubMed ID: 10587273
[TBL] [Abstract][Full Text] [Related]
9. Parafibromin Abnormalities in Ossifying Fibroma.
Costa-Guda J; Pandya C; Strahl M; Taik P; Sebra R; Chen R; Uzilov AV; Arnold A
J Endocr Soc; 2021 Jul; 5(7):bvab087. PubMed ID: 34159287
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
11. Parafibromin expression in lung normal tissue and carcinoma: its comparison with clinicopathological parameters of carcinoma.
Xia P; Wang W; Xu XY; Wang JP; Takano Y; Zheng HC
Histol Histopathol; 2011 Aug; 26(8):1039-47. PubMed ID: 21692036
[TBL] [Abstract][Full Text] [Related]
12. Periosteal osteosarcoma of the jaws: report of 2 cases.
Piattelli A; Favia GF
J Periodontol; 2000 Feb; 71(2):325-9. PubMed ID: 10711625
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical evaluation of BMP-2, -4, osteopontin, osteocalcin and PCNA between ossifying fibromas of the jaws and peripheral cemento-ossifying fibromas on the gingiva.
Ono A; Tsukamoto G; Nagatsuka H; Yoshihama Y; Rivera RS; Katsurano M; Yao M; Sasaki A
Oral Oncol; 2007 Apr; 43(4):339-44. PubMed ID: 16931115
[TBL] [Abstract][Full Text] [Related]
14. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
15. Juvenile ossifying fibroma of the jaw: a retrospective study of 15 cases.
Han J; Hu L; Zhang C; Yang X; Tian Z; Wang Y; Zhu L; Yang C; Sun J; Zhang C; Li J; Xu L
Int J Oral Maxillofac Surg; 2016 Mar; 45(3):368-76. PubMed ID: 26740351
[TBL] [Abstract][Full Text] [Related]
16. Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions.
Kaur H; Kala S; Sood A; Mridha AR; Kakkar A; Yadav R; Mishra S; Mishra D
Head Neck Pathol; 2022 Sep; 16(3):728-737. PubMed ID: 35220546
[TBL] [Abstract][Full Text] [Related]
17. HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
Wang PF; Tan MH; Zhang C; Morreau H; Teh BT
Horm Metab Res; 2005 Jun; 37(6):380-3. PubMed ID: 16001331
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma of the jaws: factors influencing prognosis.
Granowski-LeCornu M; Chuang SK; Kaban LB; August M
J Oral Maxillofac Surg; 2011 Sep; 69(9):2368-75. PubMed ID: 21288615
[TBL] [Abstract][Full Text] [Related]
19. The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.
Zheng HC; Liu JJ; Li J; Wu JC; Yang L; Zhao GF; Zhao X; Jiang HM; Huang KQ; Li ZJ
Oncotarget; 2017 Apr; 8(14):23603-23612. PubMed ID: 28223542
[TBL] [Abstract][Full Text] [Related]
20. A Clinicopathologic Analysis of 207 Cases of Benign Fibro-Osseous Lesions of the Jaws.
Phattarataratip E; Pholjaroen C; Tiranon P
Int J Surg Pathol; 2014 Jun; 22(4):326-33. PubMed ID: 24326826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
